Skip to main content

Nvidia BioNeMo enables generative AI for drug discovery

Drug discovery

Credit: Gorodenkoff/Shutterstock

Pharma companies can access the Nvidia Clara healthcare suite, including BioNeMo via Amazon SageMaker and AWS ParallelCluster

Welcome to Scientific Computing World

Already registered?  Sign in to continue reading

Not got an account?  Register for free to continue reading

Media Partners